Science Explorer Back to mapMap
Discussion
Researcher · Hospices Civils de Lyon · France

Gilles Salles

Gilles Salles publishes mostly in Pathology and Forensic Medicine, Oncology and Genetics, on topics such as Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and CAR-T cell therapy research.

ORCID 0000-0002-9541-8666 OpenAlex
World rank
#179,305
of 7,710,434 ranked researchers
Rank in France
#12,010
of 324,115
Works
1,732
Citations
81k
Citations per work
47.0
h-index
130
i10-index 683Top 0.1% in Pathology and Forensic Medicine
Gilles Salles

What does Gilles Salles research?

Gilles Salles's work is mostly in Medicine (59%), Immunology and Microbiology (6%), Biochemistry, Genetics and Molecular Biology (5%).

Health Sciences: 1,029 works · 59.4% of their workMedicine: 1,029 works · 59.4% of their workPathology and Forensic Medicine: 438 works · 25.3% of their workOncology: 313 works · 18.1% of their workGenetics: 201 works · 11.6% of their workHematology: 76 works · 4.4% of their workEverything else: 516 works · 29.8% of their workLife Sciences: 187 works · 10.8% of their workImmunology and Microbiology: 100 works · 5.8% of their workImmunology: 100 works · 5.8% of their workBiochemistry, Genetics and Molecular Biology: 87 works · 5.0% of their workMolecular Biology: 87 works · 5.0% of their workTHEIR WORKGilles Salles1,732works
Life Sciences11%Health Sciences59%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Health Sciences1,02959.4%
    1. Medicine1,02959.4%
  2. Everything else51629.8%
    1. Immunology and Microbiology1005.8%
    2. Biochemistry, Genetics and Molecular Biology875.0%
  1. 1Pathology and Forensic Medicine25% of their works
  2. 2Oncology18% of their works
  3. 3Genetics12% of their works
  4. 4Immunology6% of their works
  5. 5Molecular Biology5% of their works
  6. 6Hematology4% of their works

Research topics

Which keywords describe Gilles Salles's research?

The keywords of their largest research topics: Rituximab, Lymphoma, Classification, Molecular Profiling, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations and CAR T Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Rituximab1,5802 topics
  2. Lymphoma1,4742 topics
  3. Classification1,0871 topic
  4. Molecular Profiling1,0871 topic
  5. Prognostic Factors6883 topics
  6. Chronic Lymphocytic Leukemia4931 topic
  7. Genomic Aberrations4931 topic
  8. CAR T Cells3871 topic
  9. Chimeric Antigen Receptor3871 topic
  10. Epstein-Barr Virus1831 topic
  11. Kaposi's Sarcoma1831 topic
  12. Primary CNS Lymphoma1511 topic
  13. Prognostic Scoring System1511 topic
  14. Fc Receptors1121 topic
  15. Therapeutic Antibodies1121 topic
  16. Cutaneous Lymphomas1081 topic
  17. Mycosis Fungoides1081 topic
  18. Acute Lymphoblastic Leukemia871 topic
  19. Childhood Cancer871 topic

Where does Gilles Salles work?

Gilles Salles's main affiliation in the publication record is Hospices Civils de Lyon, France.

How many publications and citations does Gilles Salles have?

OpenAlex counts 1,732 works and 81,392 citations for Gilles Salles, an h-index of 130, ranking #179,305 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Gilles Salles. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.